CMC Pharma

What CMC Pharma does

CMC Pharma GmbH is a privately held German pharmaceutical and life sciences consulting firm founded in 2003 by Dr. Stefan Schmitz and headquartered in Bad Sobernheim, Germany, with an additional US office in Knoxville, Tennessee. The company operates as an inter-disciplinary competence network of 10+ independent senior consultants rather than a traditional employer model, delivering specialized services across the GxP-regulated domain (Good Manufacturing, Laboratory, Distribution, and Clinical Practice) for pharmaceutical, biotechnology, and medical device companies as well as their suppliers. Its service portfolio is anchored in Chemistry, Manufacturing and Controls (CMC) regulatory work and spans GxP compliance consulting, computer system validation (GAMP 5, ALCOA data integrity), FDA inspection preparation and on-site moderation, regulatory affairs document drafting (DMFs, ASMFs, CEPs, IMPDs, INDs, eCTD Modules 2.3 and 3), R&D support using Quality by Design, and structured GMP/FDA/computer validation training programs delivered both online and in-house. There is no proprietary software platform; the underlying technology is senior domain expertise, with the founder having personally moderated over 100 FDA inspections in Europe over a 20-year period and network members such as Bernard Plennevaux having conducted over 300 international audits.

The firm makes money through time-based, quote-based professional services engagements with multi-year contract cadences. Revenue is generated from two streams: consulting services for GxP compliance, FDA inspections, regulatory affairs, R&D support, and computer system validation, and training services offered online (including self-study with knowledge tests and certificates) and customized in-house at client sites. There is no public pricing list. The go-to-market motion is sales-led and reputation-driven, leveraging the founder's inspection track record, the network's collective regulatory expertise, a German-language corporate website, downloadable regulatory resources, and individual LinkedIn profiles of senior consultants. Geographic coverage spans D-A-CH, broader Europe, the United States, Canada, Singapore, and Japan, with the US office specifically focused on US FDA registration and inspection support for North American clients. The business is founder-owned, with Dr. Stefan Schmitz as the sole managing director and no disclosed institutional investors, funding rounds, or parent entities.

Name

CMC Pharma

Legal name

CMC Pharma GmbH

Website

https://cmc-pharma.de

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

CMC Pharma GmbH is a privately held German pharmaceutical and life sciences consultancy founded in 2003, operating as a network of senior GxP experts serving pharma, biotech, and medical device companies with regulatory affairs, FDA inspection support, computer system validation, and training services.

Ownership category

akta.pro rank

Product category

Pharmaceutical regulatory consulting

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC) (HLAGAKAB)

akta.pro secondary industries

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Training & Competency Programs for GxP Compliance (HLAGAKAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• GxP compliance consulting
• FDA inspection support
• Regulatory affairs services
• Computer system validation
• Pharmaceutical training

Headquarters

HQ city

Mannheim

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Consulting Services: Professional consulting for GxP compliance, FDA inspections, regulatory affairs, R&D support, and computer system validation. Billed based on engagement scope with time-based consulting model. Online consulting offers cost advantages with no travel expenses billed.
2. Training Services: Online and in-house training programs for GMP, FDA regulations, computer validation, and data integrity. Online training available as self-study with knowledge tests and certificates. Customized training packages tailored to client needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

CMC Pharma provides independent consulting, training, and specialized services for pharmaceutical, biotechnology, and medical device companies across the full GxP-regulated product lifecycle (development, manufacturing, final control, and analytics). Core offerings include GxP Compliance consulting (GMP, GLP, GDP, GCP), Computer System Validation, FDA Inspection Support (preparation, moderation, follow-up), R&D Support using Quality by Design, Regulatory Affairs document preparation (DMFs, ASMFs, CEPs, IMPDs, INDs, eCTD), and Training delivered both online and in-house.

Product overview

CMC Pharma is a consulting services company operating as a competency network that provides independent consulting, training, and specialized services for the pharmaceutical and life sciences industries as well as their suppliers. The company's service portfolio centers on the CMC (Chemistry, Manufacturing and Controls) portion of regulatory submissions, covering the entire product lifecycle from development through manufacturing to final control and analytics. The core offerings include GXP Compliance (covering GMP, GLP, GDP, and GCP), Computer System Validation, FDA Inspection Support, R&D Support using Quality by Design methodology, Regulatory Affairs document preparation (DMFs, ASMFs, CEPs, IMPDs, eCTD formats), and professional Training/Schulungen delivered both online and in-house. The Online Consulting format enables remote delivery of all these services. The company was founded over 20 years ago and has a network of interdisciplinary experts.

Differentiator

Problem solved

Functional benefit

Products and services

• GxP Compliance
• Computer System Validation (CS Validierung)
• FDA Support
• R&D Support
• Regulatory Affairs
• Training & Schulungen
• Online Consulting

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Language ProfessionalsminorStrategic or Co-development PartnerCollaboration with Language Professionals, a translation and interpretation bureau. Elisabeth Rösch and Mike Morandin are co-founders of Language Professionals alongside Miriam Söllch. Language Professionals provides interpretation services, particularly for FDA inspections and scientific/technical translation (German-Italian-English).

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Voisin Consulting Life Sciences: European regulatory and medical affairs consultancy specialized in EMA/FDA submissions and CMC support. Closely comparable to CMC Pharma's regulatory authoring and GxP advisory positioning.
• Inspired Pharma Training: UK-based specialist provider of GMP, GDP, and validation training for pharma professionals. Directly comparable to CMC Pharma's Training & Schulungen line, including online and in-house delivery.
• PharmaLex (Cencora): Regulatory affairs, quality, and pharmacovigilance consultancy now part of Cencora. Competes head-to-head with CMC Pharma on eCTD submissions, CMC regulatory support, and GxP compliance services for European and US clients.
• ProductLife Group: European regulatory, pharmacovigilance, and quality consultancy serving pharma and medical devices. Direct peer in regulatory affairs consulting and CMC support, similar mid-market positioning.
• ProPharma Group: A privately held regulatory, compliance, and quality consulting firm serving pharma, biotech, and medical device companies. Overlaps directly with CMC Pharma on GxP consulting, regulatory affairs, and CSV services for mid-market pharma clients.
• Arriello: Boutique regulatory affairs, quality, and compliance consultancy for pharma and biotech. Similar service portfolio to CMC Pharma, including CMC, GxP, and market access support across Europe.

Broad incumbents

• IQVIA: Largest global CRO/commercialization provider with technology-enabled regulatory and quality services. Adjacent to CMC Pharma's regulatory practice but competes on enterprise-scale, integrated offerings.
• ICON plc: Global CRO with regulatory and pharmacovigilance capabilities acquired through PRA Health Sciences. Broad incumbent alternative to CMC Pharma for multi-disciplinary pharma services.
• Charles River Laboratories: Preclinical and manufacturing CRO with regulatory consulting and GxP services. Comparable CMC and regulatory affairs overlap but with much broader manufacturing footprint.
• Parexel International: Global CRO offering regulatory consulting, clinical, and post-approval services. Overlaps with CMC Pharma's regulatory and GxP practice but operates at much larger scale with a full clinical/CMC platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CMC Pharma